JP2016537414A - 心臓神経堤細胞、及びその使用方法 - Google Patents

心臓神経堤細胞、及びその使用方法 Download PDF

Info

Publication number
JP2016537414A
JP2016537414A JP2016552222A JP2016552222A JP2016537414A JP 2016537414 A JP2016537414 A JP 2016537414A JP 2016552222 A JP2016552222 A JP 2016552222A JP 2016552222 A JP2016552222 A JP 2016552222A JP 2016537414 A JP2016537414 A JP 2016537414A
Authority
JP
Japan
Prior art keywords
cells
neural crest
cardiac
ckit
cardiac neural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016552222A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016537414A5 (enExample
Inventor
イー． チャッチスタゴース、コンスタンディーノス
イー． チャッチスタゴース、コンスタンディーノス
エム． ヘーア、ジョシュア
エム． ヘーア、ジョシュア
Original Assignee
ベスティオン、インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベスティオン、インク． filed Critical ベスティオン、インク．
Publication of JP2016537414A publication Critical patent/JP2016537414A/ja
Publication of JP2016537414A5 publication Critical patent/JP2016537414A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1329—Cardiomyocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
JP2016552222A 2013-10-29 2014-10-29 心臓神経堤細胞、及びその使用方法 Pending JP2016537414A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361896945P 2013-10-29 2013-10-29
US61/896,945 2013-10-29
PCT/US2014/062939 WO2015066197A2 (en) 2013-10-29 2014-10-29 Cardiac neural crest cells and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019000020A Division JP6832049B2 (ja) 2013-10-29 2019-01-04 心臓神経堤細胞、及びその使用方法

Publications (2)

Publication Number Publication Date
JP2016537414A true JP2016537414A (ja) 2016-12-01
JP2016537414A5 JP2016537414A5 (enExample) 2017-12-14

Family

ID=53005371

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016552222A Pending JP2016537414A (ja) 2013-10-29 2014-10-29 心臓神経堤細胞、及びその使用方法
JP2019000020A Expired - Fee Related JP6832049B2 (ja) 2013-10-29 2019-01-04 心臓神経堤細胞、及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019000020A Expired - Fee Related JP6832049B2 (ja) 2013-10-29 2019-01-04 心臓神経堤細胞、及びその使用方法

Country Status (4)

Country Link
US (2) US10786536B2 (enExample)
EP (1) EP3063267A4 (enExample)
JP (2) JP2016537414A (enExample)
WO (1) WO2015066197A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019049957A1 (ja) * 2017-09-08 2019-03-14 株式会社大塚製薬工場 幼若ブタ由来幹細胞およびその調製方法

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9962409B2 (en) 2007-10-01 2018-05-08 Vestion, Inc. Therapy using cardiac stem cells and mesenchymal stem cells
US10653650B2 (en) 2011-12-13 2020-05-19 Io Therapeutics, Inc. Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists
CN104114171A (zh) 2011-12-13 2014-10-22 Io治疗公司 使用rxr激动剂的自身免疫紊乱的治疗
ES2824165T3 (es) 2012-11-30 2021-05-11 Vestion Inc Células madre cardíacas y métodos de identificación y uso de las mismas
EP3426302B1 (en) 2016-03-10 2022-12-14 IO Therapeutics, Inc. Treatment of autoimmune diseases with combinations of rxr agonists and thyroid hormones
DK3426303T3 (da) * 2016-03-10 2022-09-19 Io Therapeutics Inc Behandling af muskellidelser med kombinationer af rxr-agonister og thyroideahormoner
EP3684348A4 (en) 2017-09-20 2021-08-18 IO Therapeutics, Inc. TREATMENT OF DISEASE WITH SELECTIVE RXR AGONIST ESTERS
BR112020010539A2 (pt) 2017-11-30 2020-11-17 Kyoto University métodos para produção e para proliferação de células da crista neural, para produção de células nervosas, células da glia, células estromais mesenquimais, células ósseas, condrócitos, células da córnea ou células pigmentares e para cultivar células da crista neural, meio, estoque congelado, e, uso de um meio
CN108300722A (zh) * 2018-02-11 2018-07-20 南京市妇幼保健院 用于检测先天性心脏病的基因panel及应用
CN110652515A (zh) * 2018-06-29 2020-01-07 中国科学院深圳先进技术研究院 AMPK抑制剂Compound C在治疗肿瘤药物中的应用
WO2022020794A1 (en) * 2020-07-24 2022-01-27 The Scripps Research Institute Compositions comprising neural crest cell derivatives and uses thereof
JP2024543621A (ja) 2021-12-07 2024-11-21 アイオー セラピューティクス インコーポレイテッド Ｈｅｒ２＋がんの治療におけるｒｘｒアゴニストおよびタキサンの使用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005033298A1 (ja) * 2003-10-03 2005-04-14 Keiichi Fukuda 幹細胞から心筋細胞を分化誘導する方法
US20120034595A1 (en) * 2006-11-07 2012-02-09 Keck Graduate Institute Enriched stem cell and progenitor cell populations, and methods of producing and using such populations
JP2013531497A (ja) * 2010-06-13 2013-08-08 インスティチュート・オブ・バイオフィジックス，チャイニーズ・アカデミー・オブ・サイエンシズ 幹細胞から心筋細胞を調製するための方法および組成物ならびにその使用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1007631T4 (da) 1997-07-14 2009-04-27 Osiris Therapeutics Inc Hjertemuskelregeneration ved anvendelse af mesenkymale stamceller
US6821740B2 (en) 1998-02-25 2004-11-23 Becton, Dickinson And Company Flow cytometric methods for the concurrent detection of discrete functional conformations of PRB in single cells
AU5545499A (en) 1998-07-31 2000-02-21 Genzyme Corporation Improvement of cardiac function by mesenchymal stem cell transplantation
US8075881B2 (en) 1999-08-05 2011-12-13 Regents Of The University Of Minnesota Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
US7547674B2 (en) 2001-06-06 2009-06-16 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US6930222B2 (en) 2000-08-22 2005-08-16 The Scripps Research Institute In vivo animal model of human leukemia
AU2003270051A1 (en) 2002-08-29 2004-03-19 Baylor College Of Medicine Heart derived cells for cardiac repair
CA2528869A1 (en) 2003-06-12 2004-12-23 Regents Of The University Of Minnesota Directing cells to target tissues or organs
US7082573B2 (en) 2003-07-30 2006-07-25 America Online, Inc. Method and system for managing digital assets
DE602004024125D1 (de) 2003-12-25 2009-12-24 Kanazawa University Technology Induktion einer myokardzelle unter verwendung einer säuger-knochenmarkzelle oder aus nabelschnurblut stammenden zelle und fettgewebe
WO2006039630A2 (en) 2004-10-02 2006-04-13 Indiana University Research & Technology Corporation Materials and methods for identifying compounds that modulate the cell cycle
WO2008054819A2 (en) 2006-11-02 2008-05-08 The General Hospital Corporation Cardiovascular stem cells, methods for stem cell isolation, and uses thereof
US9962409B2 (en) 2007-10-01 2018-05-08 Vestion, Inc. Therapy using cardiac stem cells and mesenchymal stem cells
WO2009073618A2 (en) * 2007-11-30 2009-06-11 New York Medical College Compositions comprising hdac inhibitors and methods of their use in restoring stem cell function and preventing heart failure
US8512696B2 (en) 2007-11-30 2013-08-20 Autologous, Llc Methods of isolating non-senescent cardiac stem cells and uses thereof
EP3399026B1 (en) * 2010-06-14 2024-06-26 The Scripps Research Institute Reprogramming of cells to a new fate
EP2750509B1 (en) * 2011-08-30 2016-12-28 The J. David Gladstone Institutes Methods for generating cardiomyocytes
US20140162366A1 (en) * 2012-08-31 2014-06-12 Salk Institute For Biological Studies Generation of vascular progenitor cells
ES2824165T3 (es) 2012-11-30 2021-05-11 Vestion Inc Células madre cardíacas y métodos de identificación y uso de las mismas
US11377639B2 (en) * 2013-11-15 2022-07-05 Wisconsin Alumni Research Foundation Lineage reprogramming to induced cardiac progenitor cells (iCPC) by defined factors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005033298A1 (ja) * 2003-10-03 2005-04-14 Keiichi Fukuda 幹細胞から心筋細胞を分化誘導する方法
US20120034595A1 (en) * 2006-11-07 2012-02-09 Keck Graduate Institute Enriched stem cell and progenitor cell populations, and methods of producing and using such populations
JP2013531497A (ja) * 2010-06-13 2013-08-08 インスティチュート・オブ・バイオフィジックス，チャイニーズ・アカデミー・オブ・サイエンシズ 幹細胞から心筋細胞を調製するための方法および組成物ならびにその使用

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ARTERIOSCLER. THROMB. VASC. BIOL., vol. 31, JPN6018024316, 2011, pages 582 - 589, ISSN: 0003991827 *
J. CELL BIOL., vol. 170, no. 7, JPN6018024321, 2005, pages 1135 - 1146, ISSN: 0003991830 *
NATURE PROTOCOLS, vol. 5, no. 4, JPN6018024323, 2010, pages 688 - 701, ISSN: 0003991831 *
STEM CELLS TRANSL. MED., vol. 1, JPN6018024318, 2012, pages 116 - 124, ISSN: 0003991828 *
田村 雄一 YUICHI TAMURA: "心臓の再生 The review of basic studies abollt the cardiac stem cell and regenerative medicine", 日本臨牀, vol. 66, no. 5, JPN6018024319, 2008, pages 908 - 914, ISSN: 0003991829 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019049957A1 (ja) * 2017-09-08 2019-03-14 株式会社大塚製薬工場 幼若ブタ由来幹細胞およびその調製方法
JPWO2019049957A1 (ja) * 2017-09-08 2020-10-15 株式会社大塚製薬工場 幼若ブタ由来幹細胞およびその調製方法
JP7628691B2 (ja) 2017-09-08 2025-02-12 株式会社大塚製薬工場 幼若ブタ由来幹細胞およびその調製方法

Also Published As

Publication number Publication date
JP6832049B2 (ja) 2021-02-24
WO2015066197A3 (en) 2015-09-11
US10786536B2 (en) 2020-09-29
US20210260133A1 (en) 2021-08-26
EP3063267A4 (en) 2017-10-18
EP3063267A2 (en) 2016-09-07
JP2019077701A (ja) 2019-05-23
WO2015066197A2 (en) 2015-05-07
US20160250261A1 (en) 2016-09-01

Similar Documents

Publication Publication Date Title
JP6832049B2 (ja) 心臓神経堤細胞、及びその使用方法
US10526581B2 (en) Modulation of cardiac stem-progenitor cell differentiation, assays and uses thereof
KR100694963B1 (ko) 이식용 세포의 생산방법
AU2011299327B2 (en) Tissue-specific differentiation matrices and uses thereof
US20080145860A1 (en) Encapsulated cell indicator system
JP2017525393A (ja) ヒト心室前駆体細胞を単離するための細胞表面マーカーとしてのＪａｇｇｅｄ１／Ｆｒｉｚｚｌｅｄ４の使用
US20070072294A1 (en) Use of human stem cells and/or factors they produce to promote adult mammalian cardiac repair through cardiomyocyte cell division
US20200360563A1 (en) Methods for Vascular Construction and Products Therefrom
JPWO2005035739A1 (ja) 再生治療システム
Sahito et al. In Vitro Grown Micro-Tissues for Cardiac Cell Replacement Therapy in Vivo.
US20230212570A1 (en) Cell-penetrating peptide-microrna conjugates for intracellular cell delivery
Chinchilla Rodríguez et al. AMD-Like Substrate Causes Epithelial Mesenchymal Transition in iPSC-Derived Retinal Pigment Epithelial Cells Wild Type but Not C3-Knockout.
JP4083024B6 (ja) 細胞移植方法及び試薬
JP2007014273A (ja) 肝組織・臓器及びその製造方法
Colunga Human pluripotent stem cell-derived mesothelium functions inregenerative medicine as a multipotent vascular progenitor
Shojaie Extracellular Matrix-Mediated Lung Epithelial Cell Differentiation

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171027

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171027

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180703

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180928

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181003

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190312